Basic Information (Switzerland) Elecon Asia SA (hereinafter referred to as “Elecon”) is a powerful intelligent three-d...
Digital Copyright Ten Major Typical Cases 1.Short Video Copyright Case: Whether a Short Video is Original Has Nothing to...
December 7, 2023 - News of a patent infringement ruling against Apple Watches a few weeks ago caused a flurry of investo...
NEW YORK, March 18 (Reuters) - A U.S. appeals court on Monday revived an antitrust lawsuit by Regeneron Pharmaceuticals (REGN.O) against Novartis (NOVN.S) related to prescription treatments to
Introduction On August 29 2017 the Supreme Court issued decisions recognising the inventiveness of two Novartis patents for a compound and a transdermal composition, covering two products used to
Novartis is breathing a sigh of relief after a U.S. federal judge upheld Novartis’ dosage regiment patents for its multiple sclerosis drug, Gilenya. The legal ruling, subject to appeal, protects the
Celltrion will not face a PI from the Unified Patent Court against its biosimilar of Novartis' asthma drug Xolair. Today, Düsseldorf local division dismissed the PI application by Novartis and
Novartis has successfully defended against an attack on its SPC protecting a treatment for chronic heart failure in the Netherlands. The Court of Appeal in The Hague dismissed a nullity suit filed by
total 1 pages, 5 items
CHINA intellectual PROPERTY LAWYERS NETWORK
+86-13910160652
ciplawyers@163.com
